These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 22092403)
1. Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissue. Sinn BV; Darb-Esfahani S; Wirtz RM; Budczies J; Sehouli J; Chekerov R; Dietel M; Denkert C Histopathology; 2011 Nov; 59(5):918-27. PubMed ID: 22092403 [TBL] [Abstract][Full Text] [Related]
2. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363 [TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer: progesterone receptor B hypermethylation in breast cancer. Mc Cormack O; Chung WY; Fitzpatrick P; Cooke F; Flynn B; Harrison M; Fox E; Gallagher E; McGoldrick A; Dervan PA; McCann A; Kerin MJ Breast Cancer Res Treat; 2008 Sep; 111(1):45-53. PubMed ID: 17896177 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of estrogen receptor and progesterone receptor status in young Chinese ovarian carcinoma patients. Yang XY; Xi MR; Yang KX; Yu H Gynecol Oncol; 2009 Apr; 113(1):99-104. PubMed ID: 19178934 [TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies. Akahira J; Inoue T; Suzuki T; Ito K; Konno R; Sato S; Moriya T; Okamura K; Yajima A; Sasano H Br J Cancer; 2000 Dec; 83(11):1488-94. PubMed ID: 11076658 [TBL] [Abstract][Full Text] [Related]
6. The detection of ESR1/PGR/ERBB2 mRNA levels by RT-QPCR: a better approach for subtyping breast cancer and predicting prognosis. Du X; Li XQ; Li L; Xu YY; Feng YM Breast Cancer Res Treat; 2013 Feb; 138(1):59-67. PubMed ID: 23397283 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study. Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554 [TBL] [Abstract][Full Text] [Related]
8. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival. Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507 [TBL] [Abstract][Full Text] [Related]
9. Effect of duration of fixation on quantitative reverse transcription polymerase chain reaction analyses. Macabeo-Ong M; Ginzinger DG; Dekker N; McMillan A; Regezi JA; Wong DT; Jordan RC Mod Pathol; 2002 Sep; 15(9):979-87. PubMed ID: 12218216 [TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer. Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875 [TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue. Darb-Esfahani S; Wirtz RM; Sinn BV; Budczies J; Noske A; Weichert W; Faggad A; Scharff S; Sehouli J; Oskay-Ozcelik G; Zamagni C; De Iaco P; Martoni A; Dietel M; Denkert C Endocr Relat Cancer; 2009 Dec; 16(4):1229-39. PubMed ID: 19675076 [TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer. Müller BM; Kronenwett R; Hennig G; Euting H; Weber K; Bohmann K; Weichert W; Altmann G; Roth C; Winzer KJ; Kristiansen G; Petry C; Dietel M; Denkert C Diagn Mol Pathol; 2011 Mar; 20(1):1-10. PubMed ID: 21326033 [TBL] [Abstract][Full Text] [Related]
13. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146 [TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens. Yamamoto S; Ibusuki M; Yamamoto Y; Fu P; Fujiwara S; Murakami K; Iwase H Breast Cancer; 2013 Jul; 20(3):262-70. PubMed ID: 22362219 [TBL] [Abstract][Full Text] [Related]
15. [Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma]. Zhang MZ; Qiao YH; Suo ZH Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):848-52. PubMed ID: 19173831 [TBL] [Abstract][Full Text] [Related]
16. Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*. Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Hara Y; Kobayashi S; Iwase H Breast Cancer Res Treat; 2005 Nov; 94(1):11-6. PubMed ID: 16172792 [TBL] [Abstract][Full Text] [Related]
17. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium. Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817 [TBL] [Abstract][Full Text] [Related]
18. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. Anders CK; Hsu DS; Broadwater G; Acharya CR; Foekens JA; Zhang Y; Wang Y; Marcom PK; Marks JR; Febbo PG; Nevins JR; Potti A; Blackwell KL J Clin Oncol; 2008 Jul; 26(20):3324-30. PubMed ID: 18612148 [TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of tumor cell expression of estrogen receptor-α, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer. Rades D; Setter C; Dahl O; Schild SE; Noack F Cancer; 2012 Jan; 118(1):157-63. PubMed ID: 21713768 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of clinicopathological characteristics and oestrogen receptor gene expression in oestrogen receptor-negative, progesterone receptor-positive canine mammary carcinomas. Kim NH; Lim HY; Im KS; Shin JI; Kim HW; Sur JH J Comp Pathol; 2014 Jul; 151(1):42-50. PubMed ID: 24913515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]